Discover Stiglitz's insights on how COVID-19 exposed health and economic inequalities and the potential backlash against ...

The FDA's new COVID-19 vaccine approval limits eligibility to high-risk individuals, diverging from previous universal recommendations. Secretary Kennedy rescinded emergency use authorizations, ...

LOS ANGELES -- Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu. New research suggests that's far from the truth. With concern over COVID ...

Pandemic revisionism has gone mainstream. More than five years after COVID-19 began spreading in the United States, a new conventional wisdom has taken hold in some quarters: Public-health officials ...

At J.P. Morgan 2026, Pfizer CEO Albert Bourla positioned the company as a post-COVID operator focused on disciplined ...

Most of us now view COVID-19 as more of a nuisance than a danger, thanks to vaccines and past exposure to the virus—all of which have built up our immunity. But research suggests that multiple ...